Home › Funds › GENERATION INVESTMENT MANAGEMENT LLP › WST
GENERATION INVESTMENT MANAGEMENT LLP position in WST
WEST PHARMACEUTICAL SVSC INC · Health Care
GENERATION INVESTMENT MANAGEMENT LLP reported holding 835,994 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$310.0M, representing 3.30% of its reported portfolio and ranking #12 among its reported holdings. GENERATION INVESTMENT MANAGEMENT LLP has disclosed WST holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GENERATION INVESTMENT MANAGEMENT LLP's WST position evolved
GENERATION INVESTMENT MANAGEMENT LLP first disclosed a stake in WST in Q2 2025 at 1,165,777 shares (US$255.1M). The position peaked in Q2 2026 at 2,028,322 shares, worth US$728.2M. Across 6 filings, GENERATION INVESTMENT MANAGEMENT LLP increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 835,994 shares valued at US$310.0M — a reduction of -1,192,328 shares quarter over quarter.. Notable position changes include a 60% increase in Q4 2025 (shares fell 9% over the following quarter), a 44% increase in Q1 2026 (shares rose 43% over the following quarter), a 59% trim in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.17M | $255.07M | New |
| Q3 2025 | 976.01K | $256.04M | Reduce |
| Q4 2025 | 1.56M | $429.73M | Add |
| Q1 2026 | 2.24M | $562.43M | Add |
| Q2 2026 | 2.03M | $728.17M | Reduce |
| Q3 2026 | 835.99K | $309.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WST and 13F data
WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 27 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), BROWN ADVISORY INC (US$346.9M), Longview Partners (Guernsey) LTD (US$343.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WST
- Artisan Partners Limited Partnership 2.01M sh · $744.42M · Q3 2026
- BROWN ADVISORY INC 935.74K sh · $346.94M · Q3 2026
- Longview Partners (Guernsey) LTD 927.47K sh · $343.87M · Q3 2026
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 687.78K sh · $255.00M · Q3 2026
More on GENERATION INVESTMENT MANAGEMENT LLP
FAQ
How long has GENERATION INVESTMENT MANAGEMENT LLP held WST?
GENERATION INVESTMENT MANAGEMENT LLP has disclosed WST holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is GENERATION INVESTMENT MANAGEMENT LLP's current position in WST?
As of Q3 2026, GENERATION INVESTMENT MANAGEMENT LLP holds 835.99K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $309.95M, representing 3.30% of its reported portfolio and ranking #12.
Has GENERATION INVESTMENT MANAGEMENT LLP been buying or selling WST?
In the latest 13F filing (Q3 2026), GENERATION INVESTMENT MANAGEMENT LLP reduced its position in WST. The position peaked in Q2 2026 at 2.03M shares.
Which other funds hold WST?
Other major institutional holders of WST include Artisan Partners Limited Partnership, BROWN ADVISORY INC, Longview Partners (Guernsey) LTD, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.